Sigma Investment Counselors Inc. Increases Stake in Synopsys, Inc. $SNPS

Sigma Investment Counselors Inc. raised its position in Synopsys, Inc. (NASDAQ:SNPS) by 4.1% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 26,112 shares of the semiconductor company’s stock after purchasing an additional 1,038 shares during the period. Sigma Investment Counselors Inc.’s holdings in Synopsys were worth $13,387,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in SNPS. Vanguard Group Inc. raised its holdings in shares of Synopsys by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock worth $6,359,747,000 after acquiring an additional 346,994 shares during the period. Pictet Asset Management Holding SA grew its position in Synopsys by 38.3% in the 1st quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock valued at $1,043,518,000 after acquiring an additional 673,837 shares in the last quarter. Ameriprise Financial Inc. grew its position in Synopsys by 6.6% in the 1st quarter. Ameriprise Financial Inc. now owns 2,013,380 shares of the semiconductor company’s stock valued at $863,500,000 after acquiring an additional 125,199 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Synopsys by 20.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company’s stock worth $778,928,000 after buying an additional 305,489 shares in the last quarter. Finally, Alliancebernstein L.P. grew its position in shares of Synopsys by 22.2% during the first quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock worth $739,857,000 after buying an additional 313,218 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Synopsys Price Performance

SNPS stock opened at $447.64 on Friday. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The stock’s 50 day moving average is $525.72 and its two-hundred day moving average is $510.73. The company has a market capitalization of $83.15 billion, a PE ratio of 35.14, a P/E/G ratio of 4.93 and a beta of 1.10.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing the consensus estimate of $3.75 by ($1.45). The firm had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. Synopsys had a return on equity of 10.82% and a net margin of 31.04%.Synopsys’s revenue was up 14.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $3.43 EPS. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on SNPS shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Synopsys in a report on Wednesday, October 8th. Wall Street Zen cut Synopsys from a “hold” rating to a “sell” rating in a research report on Saturday, September 13th. Bank of America reiterated an “underperform” rating and issued a $525.00 price objective (down previously from $625.00) on shares of Synopsys in a research report on Wednesday, September 10th. Piper Sandler dropped their price target on Synopsys from $660.00 to $630.00 and set an “overweight” rating for the company in a research report on Wednesday, September 10th. Finally, BNP Paribas began coverage on Synopsys in a research note on Thursday, October 2nd. They set an “underperform” rating and a $425.00 price objective on the stock. Ten equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and four have given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $569.67.

Insiders Place Their Bets

In other Synopsys news, CFO Shelagh Glaser sold 3,655 shares of Synopsys stock in a transaction on Friday, September 5th. The stock was sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the sale, the chief financial officer owned 15,317 shares of the company’s stock, valued at $9,339,847.09. The trade was a 19.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the business’s stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total value of $6,694,687.66. Following the completion of the sale, the chief executive officer directly owned 71,615 shares in the company, valued at $42,181,951.15. This represents a 13.70% decrease in their position. The disclosure for this sale can be found here. Insiders sold 30,894 shares of company stock worth $16,760,783 over the last 90 days. Insiders own 0.62% of the company’s stock.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.